Gautham Nadig is co-founder of Mynvax, a clinical stage biotech company incubated at the Indian Institute of Science, Bangalore. Mynvax develops innovative vaccine products for respiratory infectious diseases. Prior to founding Mynvax, he was co-founder of a successful agribiotechnology company, Metahelix which developed many innovative biotech products including transgenic crops, superior hybrid seeds in field and vegetable crops. Metahelix was acquired by Rallis, a subsidiary of Tata Chemicals in 2016. Gautham is involved with a number of biotech start-ups in various capacities including advisory, board roles as well as an early-stage investor. He graduated with a Ph.D. in computational structural biology from the Indian Institute of Science in 1997.